Stock Analysis

Feedback Full Year 2024 Earnings: UK£0.25 loss per share (vs UK£0.22 loss in FY 2023)

AIM:FDBK
Source: Shutterstock

Feedback (LON:FDBK) Full Year 2024 Results

Key Financial Results

  • Revenue: UK£1.18b (up by UK£1.18b from FY 2023).
  • Net loss: UK£3.30b (loss widened by UK£3.30b from FY 2023).
  • UK£0.25 loss per share (further deteriorated from UK£0.22 loss in FY 2023).
earnings-and-revenue-history
AIM:FDBK Earnings and Revenue History November 5th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Feedback Earnings Insights

Looking ahead, revenue is expected to decline by 149% p.a. on average during the next 2 years, while revenues in the Healthcare Services industry in Europe are expected to grow by 8.2%.

Performance of the market in the United Kingdom.

The company's shares are down 52% from a week ago.

Risk Analysis

Before you take the next step you should know about the 3 warning signs for Feedback that we have uncovered.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.